Credit Suisse
-
Dongxing Securities Co leaned on the support of 19 lead banks to close its $400m bond return against a difficult market backdrop. -
Credit Suisse's head of Greater China debt capital markets has quit the bank, according to sources.
-
Chinese biotechnology company Venus Medtech (Huangzhou) is seeking approval to list in Hong Kong, having filed a draft prospectus with the city’s bourse on Monday.
-
Asia’s primary bond market was quiet for the second day in a row on Tuesday, as investors continued to remain wary about rising tensions between the US and China.
-
Indian microloan provider Spandana Sphoorty Financial kicked off a two-day bookbuilding for its up to Rp12.01bn ($169.9m) IPO on Monday morning.
-
Central China Real Estate and Shandong Chenming Paper Holdings have raised a combined $463m from dollar bond investors amid a weak market backdrop.
-
Credit Suisse has appointed Le Hoai Nam to lead its Vietnam investment banking and capital markets coverage, according to a source familiar with the matter.
-
-
Banks are racing to expand their sponsors coverage teams as they fight to remain relevant to private capital providers at a time of disintermediation in investment banking. By David Rothnie.
-
Underwriting revenues fell for Credit Suisse in the second quarter, it said on Wednesday, although fixed income trading and sales was a bright spot in its results.
-
Dexin China Holdings Co found limited interest for its debut dollar bond, despite paying a generous yield to get the deal done.
-
GEMS Education came to the market on Tuesday with a pair of seven year senior secured bonds. The issues form part of a larger debt package being raised to support private equity firm CVC Capital Partners purchase a minority stake in the Dubai-headquartered education provider.
